# Kenneth Lee Kelln – FDA Inspection, Oct 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/kenneth-lee-kelln/7cef70f1-2c7b-42c3-8f96-b697b8db8c48
Source feed: FDA_Inspections

> FDA inspection 1031520 of Kenneth Lee Kelln, October 31, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031520
- Company Name: Kenneth Lee Kelln
- Inspection Date: 2017-10-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/stephen-t-hansen/7ae1f1df-7f68-4264-bd87-ea21c8d879bb)

Company: https://www.keypedia.com/companies/kenneth-lee-kelln/971ab6c9-316e-45c2-ad3a-4e5717c5bb67

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c